Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient-Reference-Cited by-同舟云学术

Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient

Published:2022-07 Issue:7 Volume:28 Page:1001-1004
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Shoji Kosuke,Suzuki Akira^ORCID,Okamoto Michiko^ORCID,Tsinda Emmanuel Kagning^ORCID,Sugawara Naoko,Sasaki Mie,Nogami Yoshihiko,Kobayashi Michio,Oshitani Hitoshi,Yanai Masaru

Funder

Japan Agency for Medical Research and Development

Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference16 articles.

1. Phylogenetic and phylodynamic analyses of SARS-CoV-2;Nie;Virus Res,2020

2. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer;Avanzato;Cell,2020

3. Persistence and evolution of SARS-CoV-2 in an immunocompromised host;Choi;N Engl J Med,2020

4. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer;Aydillo;N Engl J Med,2020

5. SARS-CoV-2 variants in patients with immunosuppression;Corey;N Engl J Med,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies;Virology Journal;2024-05-07

2. Radiologic Abnormalities in Prolonged SARS-CoV-2 Infection: A Systematic Review;Korean Journal of Radiology;2024

3. Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study;Journal of Korean Medical Science;2024

4. SARS‐CoV‐2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment;Journal of Medical Virology;2023-06

5. The origins of new SARS-COV-2 variants in immunocompromised individuals;Current Opinion in HIV and AIDS;2023-03-28